Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel B Mark

Showing results (111-120 of 331) with videos related to

Pageof 34
Sort By:
American Heart Journal|October 27, 2009
Reporting and representation of race/ethnicity in published randomized trialsJeffrey S Berger, Chiara Melloni, Tracy Y Wang, et al.
Journal of the American College of Cardiology|July 9, 2021
Ablation Versus Drug Therapy for Atrial Fibrillation in Racial and Ethnic MinoritiesKevin L Thomas, Hussein R Al-Khalidi, Adam P Silverstein, et al.
Archives of Internal Medicine|March 2, 2011
Recovery expectations and long-term prognosis of patients with coronary heart diseaseJohn C Barefoot, Beverly H Brummett, Redford B Williams, et al.
The New England Journal of Medicine|September 5, 2008
Quality of life with defibrillator therapy or amiodarone in heart failureDaniel B Mark, Kevin J Anstrom, Jie L Sun, et al.
Journal of the American College of Cardiology|April 15, 2014
Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)Daniel P Fishbein, Anne S Hellkamp, Daniel B Mark, et al.
Heart Rhythm|November 27, 2010
Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Jonathan P Piccini, Sana M Al-Khatib, Anne S Hellkamp, et al.
Journal of Cardiovascular Electrophysiology|April 1, 2008
Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure TrialAndrea M Russo, Jeanne E Poole, Daniel B Mark, et al.
The American Journal of Cardiology|September 30, 2017
Comparison of Incidence of Left Ventricular Systolic Dysfunction Among Patients With Left Bundle Branch Block Versus Those With Normal QRS DurationEdward Sze, Allison Dunning, Zak Loring, et al.
Lancet (London, England)|August 29, 2003
Depression as a risk factor for mortality after coronary artery bypass surgeryJames A Blumenthal, Heather S Lett, Michael A Babyak, et al.
Chest|July 24, 2008
The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Richard C Becker, Thomas W Meade, Peter B Berger, et al.
Pageof 34

Showing results (111-120 of 331) with videos related to

Sort By:
Pageof 34
American Heart Journal|October 27, 2009
Reporting and representation of race/ethnicity in published randomized trialsJeffrey S Berger, Chiara Melloni, Tracy Y Wang, et al.
Journal of the American College of Cardiology|July 9, 2021
Ablation Versus Drug Therapy for Atrial Fibrillation in Racial and Ethnic MinoritiesKevin L Thomas, Hussein R Al-Khalidi, Adam P Silverstein, et al.
Archives of Internal Medicine|March 2, 2011
Recovery expectations and long-term prognosis of patients with coronary heart diseaseJohn C Barefoot, Beverly H Brummett, Redford B Williams, et al.
The New England Journal of Medicine|September 5, 2008
Quality of life with defibrillator therapy or amiodarone in heart failureDaniel B Mark, Kevin J Anstrom, Jie L Sun, et al.
Journal of the American College of Cardiology|April 15, 2014
Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)Daniel P Fishbein, Anne S Hellkamp, Daniel B Mark, et al.
Heart Rhythm|November 27, 2010
Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Jonathan P Piccini, Sana M Al-Khatib, Anne S Hellkamp, et al.
Journal of Cardiovascular Electrophysiology|April 1, 2008
Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure TrialAndrea M Russo, Jeanne E Poole, Daniel B Mark, et al.
The American Journal of Cardiology|September 30, 2017
Comparison of Incidence of Left Ventricular Systolic Dysfunction Among Patients With Left Bundle Branch Block Versus Those With Normal QRS DurationEdward Sze, Allison Dunning, Zak Loring, et al.
Lancet (London, England)|August 29, 2003
Depression as a risk factor for mortality after coronary artery bypass surgeryJames A Blumenthal, Heather S Lett, Michael A Babyak, et al.
Chest|July 24, 2008
The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Richard C Becker, Thomas W Meade, Peter B Berger, et al.
Pageof 34